Okkes Kuybu
Neurology · Redding, CANPI 1336502707
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (57.8%), food and beverage and gifts — rather than concentrated in one kind of arrangement. 15 manufacturers reported payments, led by Medtronic at 40.4% of the total.
Across 129 payments — averaging $80.87 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$4K
- Stryker$3K
- Medical Device Business Services, Inc.$1K
- Microvention, Inc.$842
- Imperative Care, Inc$682
- Johnson & Johnson$336
- plus $501 from 9 others
What the payments were for
- Travel & lodging$6,03358%
- Food & beverage$4,39542%
- Gifts$40%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 46 | $4,210 |
| Stryker | 24 | $2,793 |
| Medical Device Business Services, Inc. | 9 | $1,069 |
| Microvention, Inc. | 19 | $842 |
| Imperative Care, Inc | 10 | $682 |
| Johnson & Johnson | 8 | $336 |
| Penumbra, Inc. | 3 | $195 |
| AstraZeneca | 1 | $124 |
| Balt USA, LLC | 2 | $37 |
| Neurocrine Biosciences, Inc. | 1 | $35 |
| Inspiremd Ltd | 1 | $32 |
| AbbVie | 2 | $27 |
| Cook Medical LLC | 1 | $19 |
| Immedica Pharma US, Inc. | 1 | $17 |
| Sanofi | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- KYPHON EXPRESS II KYPHOPAK TRAY$1,844
- EVOLVE$1,695
- Pipeline$1,082
- TRUFILL$988
- Pulsar Vascular PulseRider Aneurysm Neck Reconstruction Device$849
- OPTABLATE$519
- SPINEJACK$519
- ZOOM 88-T LARGE DISTAL PLATFORM$467
- RUBY Coil$166
- Embotrap$144
- SOLIRIS$124
- STENT$123
- HYDROSOFT ADVANCED$123
- WEB Aneurysm Embolization System$123
How this compares
$10,432 in reported general payments places this provider in the 75th percentile of 1,996 neurology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 14 | $182 |
| Baclofen | 14 | $167 |
Paid to pharmacies, not to this prescriber.
Other neurology in Redding
- Andrew BlumenfeldCarlsbad$4.9M
- Khashayar DashtipourLoma Linda$3.3M
- Regina BerkovichWest Hollywood$3M
- Daniel BandariNewport Beach$2.6M
- Perry ShiehLos Angeles$2.4M
- Sandeep ThakkarIrvine$2M
- David LiebeskindLos Angeles$1.9M
- Jack SchimCarlsbad$1.7M
- Parshaw DorrizMission Viejo$1.5M
- Benjamin FrishbergCarlsbad$1.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.